CAPR Capricor Therapeutics Inc

Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.

$2.96  +0.07 (2.42%)
As of 12/06/2021 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/24/2002
Outstanding shares:  24,149,155
Average volume:  205,164
Market cap:   $69,791,058
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    14070B309
ISIN:        US14070B3096
Valuation   (See tab for details)
PE ratio:   -5.08
PB ratio:   1.95
PS ratio:   230.54
Return on equity:   -49.03%
Net income %:   -5,949.21%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy